Navigation Links
State Sen. Jeff Klein launches Einstein's new lab
Date:11/15/2011

November 15, 2011 (BRONX, NY) New York State Senator Jeffrey D. Klein joined administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University last Friday to officially open their new Cognitive Neurophysiology Laboratory. Several pieces of high-tech diagnostic and monitoring equipment, including advanced electroencephalogram (EEG) systems, stimulus delivery equipment and specialized video recording devices, were purchased through a $1 million capital grant that Senator Klein secured for Einstein in the 2009-2010 budget cycle.

The mission of the Cognitive Neurophysiology Lab is to understand how the brain function of individuals with disorders such as autism, attention deficit disorder and childhood schizophrenia differs from that of their typically-developing peers. The facility includes a new 5,000-square-foot lab housing specially-designed rooms that allow researchers to control sound and other stimuli and the latest tools to monitor the responses of study participants and patients. The ultimate goal of the lab is to use the information collected to advance the field and develop targeted intervention programs.

"There's still so much we need to learn about these types of brain disorders" said Senator Klein. "That's why I am pleased we were able to secure these needed funds for our outstanding medical institution, Albert Einstein College of Medicine. It's my hope that the Bronx can continue to lead the way for this type of medical research and innovation and that our residents will be better for it."

"Once again, Senator Klein has demonstrated his commitment to helping Einstein fulfill its mission as a leader in translational research," said Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein. "In conjunction with our National Institutes of Health-funded Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, the Cognitive Neurophysiology Lab will contribute to our essential understanding of the brain and ultimately help improve patient care."

"The construction and outfitting of the Cognitive Neurophysiology Lab was greatly assisted by the New York State capital budget funding secured by Senator Klein," said John Foxe, Ph.D., director of research at Einstein's Children's Evaluation and Rehabilitation Center and professor of pediatrics and of neuroscience. "With this support, I was able to return to Einstein to lead an outstanding team of researchers and clinicians searching for the causes of and treatments for intellectual and developmental disabilities."

The grant was used to construct the lab and adjoining office space for researchers and to buy equipment, including four high-density EEG recording systems; electrically shielded sound attenuated booths made by a local company in the Bronx (International Acoustics Corporation); stimulus delivery equipment; high-resolution eye-tracking systems; direct feed video and infrared cameras; and a projection screen for visual experiments.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Only a third of US state police agencies equip cars with AEDs
2. Could Womens Use of the Pill Raise Mens Prostate Cancer Risk?
3. Iowa State study finds health value to children of National School Lunch Program
4. Prostate cancer surgery better at teaching hospitals
5. Wayne State therapeutic marijuana use study could impact state policies, guide treatment
6. Radiation Plus Hormone Therapy Extends Life in High-Risk Prostate Cancer
7. Wayne State creating computer-based drug intervention for at-risk post-partum women
8. Ohio State researchers design a viral vector to treat a genetic form of blindness
9. More radionuclide therapy is better for prostate cancer patients
10. Preterm birth rate shows three year improvement in most states
11. Michigan State University tackles health needs of an aging statewide population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Datta ... M.D. has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a ... Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation ... Leadership in Neurology Award (PLINA). The couple joins a prestigious list of past ... Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: